LEXINGTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today announced that the company will participate in the following upcoming investor conferences: Citi's 2025 Biopharma Back to School Conference: Fireside chat at 4:00 p.m. ET on Tuesday, September 2, 2025, in Boston, MA, during which the company plans to highlight preclinical data supporting its non-viral delivery platform l ...

Ongoing Phase 1 APOLLO study investigating MT-601 in patients with relapsed B cell lymphoma showed 66% of Non-Hodgkin Lymphoma (NHL) patients achieving objective response rates, with 50% demonstrating complete response (CR) Favorable safety profile observed in study participants with no dose limiting toxicities (DLTs) or immune-effector cell associated neurotoxicity syndrome (ICANS) in the dose escalation cohort Dose expansion phase of study will investigate MT-601 at pre-specified maximum dose in patients ...

Core Viewpoint - Tango Therapeutics, Inc. is actively participating in the 2025 Cantor Global Healthcare Conference, highlighting its commitment to engaging with investors and the healthcare community [1]. Company Overview - Tango Therapeutics is a clinical-stage biotechnology company focused on discovering novel drug targets and advancing precision medicine for cancer treatment [3]. - The company employs the genetic principle of synthetic lethality to develop therapies targeting critical cancer-related pathways [3]. - More information about the company can be found on its official website [3]. Event Details - Barbara Weber, M.D., the President and CEO of Tango Therapeutics, will participate in a fireside chat at the conference on September 3, 2025, from 2:45 to 3:15 PM ET [1]. - A live webcast of the event will be available on the company's website, with a replay accessible for 90 days post-presentation [2].

Company Overview - Balchem Corporation is a global specialty ingredient manufacturer focused on health and nutrition markets [2] - The company operates through three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [2] Business Segments - The Human Nutrition & Health segment provides customized food and beverage ingredient systems and key nutrients for food, supplement, and pharmaceutical applications [2] - The Animal Nutrition & Health segment supplies products to various animal health markets [2] - Specialty Products segment offers specialty-packaged chemicals for healthcare and other industries, as well as chelated minerals for the micronutrient agricultural market [2] Upcoming Events - Balchem Corporation will present at the H.C. Wainwright 27 Annual Global Investment Conference on September 9, 2025, with key executives participating [1]

Core Viewpoint - Helium Evolution Incorporated (HEVI) has secured a strategic financing agreement with ENEOS Xplora Inc. for a convertible note valued at $8.3 million, increasing ENEOS Xplora's total investment in HEVI to $12.8 million, which will support HEVI's operations and growth in the helium sector [1][3]. Financing Details - The proceeds from the convertible note will fund HEVI's 20% working interest in the Soda Lake Facility and support drilling activities in the Mankota area, with operations expected to commence in Q4 2025 [2]. - The financing is set to close on August 29, 2025, and the note is convertible into common shares at a minimum price of $0.205 per share, subject to certain milestones [4][5]. Production and Royalties - HEVI has granted ENEOS USA a gross overriding royalty (GORR) on production from three designated wells tied into the Soda Lake Facility, structured on a sliding scale based on gross sales [6][9]. - The GORR includes 5% of gross sales in the first year, decreasing to 2% thereafter, which aligns with HEVI's production strategy [9]. Strategic Importance - This financing is viewed as a significant step in HEVI's growth trajectory, enhancing its financial foundation and positioning the company as a near-term helium producer [3]. - The Soda Lake Facility is considered a cornerstone project that will provide stable processing capacity and growth opportunities for shareholders [3]. Company Background - Helium Evolution is recognized as holding the largest helium land rights position in North America among publicly traded companies, with over five million acres under permit in southern Saskatchewan [14]. - The company aims to become a leading supplier of sustainably-produced helium to meet the growing global demand [14].

Core Viewpoint - Golden Heaven Group Holdings Ltd. has announced a share consolidation on a 15 for 1 ratio to regain compliance with Nasdaq listing requirements, effective August 28, 2025 [1][2]. Group 1: Share Consolidation Details - The share consolidation will automatically combine every 15 ordinary shares into one ordinary share without requiring action from shareholders [3]. - No fractional shares will be issued; shareholders will receive one full share instead of any fractional share resulting from the consolidation [3]. - The authorized share capital will remain at US$6,018,000,000 but will change the structure of Class A and Class B ordinary shares, with Class A shares decreasing from approximately 36.9 million to about 2.46 million shares, and Class B shares decreasing from approximately 1.07 million to about 71,574 shares [4]. Group 2: Company Overview - Golden Heaven operates amusement parks, water parks, and complementary recreational facilities in China, offering a variety of experiences including thrilling rides, water attractions, and entertainment events [5].

SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company pioneering advanced treatments for cancers throughout the body, today announced that members of its senior leadership team will participate in and be available for one-on-one meetings with investors at the following upcoming conferences. Cantor Global Healthcare Conference – Fireside ChatDate: Thursday, September 4, 2025Time: 1:00 p.m. - 1:30 p.m. ET ...

SAN MATEO, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences. Cantor Global Healthcare Conference in New York on September 3, 2025, with a fireside chat at 1:35 p.m. ET / 10:35 a.m. PT; andH.C. Wainwright 27th Annual Global Investment Conference in New York on Se ...

Core Insights - OLAPLEX has announced its first acquisition of Purvala Bioscience, a Boston-based biotech company, marking a significant step in its commitment to product innovation after ten years since its launch [1][3] - Purvala focuses on developing bioinspired technologies for health and beauty, aiming to create high-performing molecules inspired by natural biological structures [2] - OLAPLEX's CEO emphasized the company's foundation on innovation and the potential to integrate Purvala's technologies to enhance its product offerings, particularly its bond-building technology [3] Company Overview - OLAPLEX, founded in 2014, revolutionized the hair care industry with its Complete Bond Technology™, which protects and strengthens hair during and after services [4] - The company has expanded its product line to include a full suite of hair health formulas, sold globally through various channels including professional and direct-to-consumer [4] - The acquisition of Purvala is expected to drive the next generation of science-backed product innovations, aligning with OLAPLEX's mission to deliver transformative results for stylists and customers [3][4]

THE WOODLANDS, Texas, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Ring Energy, Inc. (NYSE American: REI) (“Ring” or the “Company”) today reported its debt reduction target for the third quarter of 2025 and the change in ownership status of a previous large stockholder. Ring Energy has established a debt reduction target of approximately $18 million for the third quarter of 2025. The Company anticipates it will have approximately $430 million in borrowings outstanding on its credit facility as of September 30, 2025, d ...